Unlike ageing, longevity is sexually transmitted;La longévité est sexuellement transmissible, contrairement au vieillissement

Medecine et Longevite

Volumn 2, Issue 3, 2010, Pages 114-128

  Hayflick, L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Age associated disease; Aging; Biogerontology; Cell senescence; Immortal cancer cells; Longevity determinants; Mortal normal cells; Telomerase; Telomeres

Indexed keywords

TELOMERASE;

CANCER CELL; CELL AGING; CELL CULTURE; CELL DIVISION; CELL POPULATION; DNA REPLICATION; ENERGY; GENOME; HUMAN; HUMAN CELL; IN VIVO STUDY; LONGEVITY; MOLECULAR MECHANICS; REPRODUCTION; REVIEW; SENESCENCE; SYNTHESIS; TELOMERE; THERMODYNAMICS;

EID: 77956925679     PISSN: 18757170     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mlong.2010.07.004     Document Type: Review

References (91)

1. Olshansky S.J., Hayflick L., Carnes B.A. No truth to the fountain of youth. Sci Am 2002, 286:92-95.
2. Hayflick L., Moorhead P.S. The serial cultivation of human diploid cell strains. Exp Cell Res 1961, 25:585-621.
3. Hayflick L. The limited in vitro lifetime of human diploid cell strains. Exp Cell Res 1965, 37:614-636.
4. Harrison R.G. Observations on the living developing nerve fiber. Proc Soc Exp Biol Med 1907, 4:140.
5. Earle W.R. Production of malignancy in vitro IV The mouse fibroblast cultures and changes seen in living cells. J Natl Cancer Inst 1943, 4:165.
6. Gey G.O., Coffman W.D., Kubicek M.T. Tissue culture studies of the proliferative capacity of cervical carcinoma and normal epithelium. Cancer Res 1952, 12:264-265.
7. Hayflick L. The future of ageing. Nature 2000, 408:37-39.
8. Wright W.E., Hayflick L. Nuclear control of cellular aging demonstrated by hybridization of anucleate and whole cultured normal human fibroblasts. Exp Cell Res 1975, 96:113-121.
9. Muggleton-Harris A.L., Hayflick L. Cellular aging studied by the reconstruction of replicating cells from nuclei and cytoplasms isolated from normal human diploid cells. Exp Cell Res 1976, 103:321-330.
10. Martin G.M., Sprague C.A., Epstein C.J. Replicative lifespan of cultivated human cells. Effect of donor's age, tissue and genotype. Lab Invest 1970, 23:86-92.
11. Goldstein S., Moerman E.J., Soeldner J.S., Gleason R.E., Barnett D.M. Chronologic and physiological age effect replicative life span of fibroblasts from diabetics, prediabetics, and normal donors. Science 1978, 199:781-782.
12. Schneider E.L., Mitsui Y. The relationship between in vitro cellular aging and in vivo human aging. Proc Natl Acad Sci U S A 1976, 73:3584-3588.
13. Vracko R., McFarland B.M. Life span of diabetic and non diabetic fibroblasts in vitro. Exp Cell Res 1980, 129:345-350.
14. LeGuilly Y., Simon M., Lenoir P., Bourel M. Long-term culture of human adult liver cell. Morphological changes related to in vitro senescence and effect of donor's age on growth potential. Gerontologica 1973, 19:303-313.
15. Bierman E.L. The effect of donor age on the in vitro lifespan of cultured human arterial smooth-muscle cells. In Vitro 1977, 14:951-955.
16. Tassin J., Malaise E., Courtois Y. Human lens cells have an in vitro proliferative capacity inversely proportional to the donor age. Exp Cell Res 1979, 123:388-392.
17. Walford R.L. Studies in immunogerontology. J Am Geriat Soc 1982, 30:617-625.
18. Walford R.L., Jawaid S.W., Naeim F. Evidence for in vitro senescence of T-lymphocytes cultured from normal human peripheral blood. Age 1981, 4:67-70.
19. Rubin H. Cell aging in vivo and in vitro. Mech Ageing Dev 1997, 98:1-35.
20. Cristofalo V.J., Allen R.G., Pignolo R.J., Martin B.G., Beck J.C. Relationship between donor age and the replicative lifespan of human cells in culture: a reevaluation. Proc Natl Acad Sci U S A 1998, 95:10614-10619.
21. Smith J., Hayflick L. Variation in the life span of clones derived from human diploid cell strains. J Cell Biol 1974, 62:48-53.
22. Tyrrell D.A.J., Bynoe M.L., Buckland F.E., Hayflick L. The cultivation in human embryo cells of a virus (DC) causing colds in man. Lancet 1962, 2:320-322.
23. Hayflick L., Plotkin S.A., Norton T.W., Koprowski H. Preparation of Poliovirus vaccines in a human fetal diploid cell strain. Amer J Hyg 1962, 75:240-258.
24. Hayflick L. History of cell substrates used for human biologicals. In: Hayflick L, Hennessen W, Karger SAG (Eds.). Developments in biological standardization, continuous cell lines as substrates for biologicals proceedings of the international association of biological standardization. Switzerland: Basel; 1989, 70, p. 11-26.
25. Hayflick L. A brief history of cell substrates used for the preparation of human biologicals. In: Brown F, Krause P, Lewis AM (Eds.). Evolving scientific and regulatory perspectives on cell substrates for vaccine development. Dev Biol Standards. Karger: Basel; 2001, 106, p. 5-23.
26. Fletcher M.A., Hessel L., Plotkin S.A. Human diploid cell strains (HDCS) viral vaccines. Dev Biol Stand 1998, 93:97-107.
27. Hayflick L. The coming of age of WI-38. Advances in cell culture 1984, 3. Academic Press, Orlando, Florida, p. 303-16.
28. Brookchin D, Schumacher J. The virus and the vaccine. NYC: St. Martin's Press; 2004.
29. Ebeling A.H. Dr. Carrel's immortal chicken heart. Sci Am 1942, 166:22-24.
30. Parker R.C. Methods of tissue culture 1961, Harper and Row, New York.
31. Witkowski J.A. Alexis Carrel and the mysticism of tissue culture. Med Hist 1979, 23:279-296.
32. Witkowski J.A. Dr Carrel's immortal cells. Med Hist 1980, 24:129-142.
33. Witkowski J.A. The myth of cell immortality. Trends Biochem Sci 1985, 10:258-260.
34. Hayflick L. Citation classics. Institute for Scientific Information 1978;26:12.
35. Garfield E. Current comments, Most cited articles of the 1960s 3 preclinical basic research. Institute for Scientific Information 1980;5:5-13.
36. Garfield E. The articles most cited in 1961-1982 (2) Another 100 Citation Classics, Current Contents. Institute for Scientific Information 1984;29:3-12.
37. Hayflick L. WI-38 - From Purloined cells to national policy, Citation Classic, Institute for Scientific Information 1990;3:14.
38. Pendlebury D. Institute for Scientific Information 1999 (personal communication).
39. Hayflick L. A novel technique for transforming the theft of mortal human cells into praiseworthy federal policy. Exp Gerontol 1998, 33:191-207.
40. Montgomery PO'B, Cook J.E., Reynolds R.C., Paul J.S., Hayflick L., et al. The response of single human cells to zero gravity. In Vitro 1978, 14:165-173.
41. Ref: 447, US 303,100 S Ct 2204, 65 L Ed 2d 144, 206 USPQ 193.
42. United States Patent Office, Rubella. Vaccine and method, No. 3,660,565, May 2, 1972.
43. United States Patent Office, method of producing rabies. Vaccine, No. 3,397,267, August 13, 1968.
44. Codified in 35 USC § 200-212, and implemented by 37 CFR 401 1 Campbell Plastics Engineering & Mfg, Inc v Les Brownlee, 389 F3d 1243 (Fed Cir 2004). Also, see Cornell University Law School, Legal information Institute, US Code Collection, " Chapter 18 - Patent rights in inventions made with federal assistance" and US Government Printing Office Title 37 - Patents, Trademarks, and Copyrights, " Chapter IV - Assistant Secretary for technology policy, Department of Commerce Part 401 - " Rights to inventions made by non profit organizations and small business firms under government grants, contracts, and cooperative agreements"
45. NIH Report P-27-211. Available upon request from the NIH under the Freedom of Information Act 1976.
46. Walsh J. President tells agencies to lower patent bars. Science 1983, 219:1408-1409.
47. Strehler, et al. Hayflick - NIH settlement. Science 1982;215:240-1.
48. Wade N. The rise and fall of a cell line. Science 1976, 192:125-127.
49. Letter to L. Hayflick from Nicholas Wade, January 3, 1990.
50. Nelkin D. Science as intellectual property: who controls scientific research in American Association for the advancement of science series on issues in science and technology 1984, Macmillan Publishing Co, p. 19-20.
51. Muller H.J. The remaking of chromosomes. Studies of genetics: the selected papers of HJ Muller 1962, Indiana University Press, Bloomington, p. 384-408.
52. McClintock B. The stability of broken ends of chromosomes in Zea mays. Genetics 1941, 26:234-282.
53. Olovnikov A.M. Principles of marginotomy in template synthesis of polynucleotides. Dokl Akad Nauk U S S S R 1971, 201:1496-1499.
54. Olovnikov A.M. A theory of marginotomy: the incomplete copying of template margin in enzyme synthesis of polynucleotides and biological significance of the problem. J Theoret Biol 1973, 41:181-190.
55. Olovnikov A.M. Telomeres, telomerase and aging: origin of the theory. Exp Geront 1996, 31:443-448.
56. Watson J.D. Origin of concatemeric T7 DNA. Nat New Biol 1972, 239:197-201.
57. Blackburn E.H., Gall J.G. A tandemly repeated sequence at the termini of the extrachromosomal ribosomal RNA genes in Tetrahymena. J Mol Biol 1978, 120:33-53.
58. Moyzis R.K., Buckingham J.M., Cram L.S., Dani M., Deaven L.L., Jones M.D., et al. A highly conserved repetitive DNA sequence (TTAGGG)n, present at the telomeres of human chromosomes. Proc Natl Acad Sci 1988, 85:6622-6626.
59. Henderson E. Telomere DNA structure. Telomeres 1995, 11-34. Cold Spring Harbor Laboratory Press. E.H. Blackburn, C.W. Greider (Eds.).
60. Harley C.B., Futcher A.B., Greider C.W. Telomeres shorten during ageing of human fibroblasts. Nature 1990, 345:458-460.
61. Levy M.Z., Allsopp R.C., Futcher A.B., Grieder C.W., Harley C.B. Telomere end-replication problem and cellular aging. J Molec Biol 1992, 225:951-960.
62. Lindsey J., McGill N.I., Lindsey L.A., Green D.K., Cooke H.J. In vivo loss of telomere repeats with age in humans. Mutat Res 1991, 256:45-48.
63. Weng N.P. Interplay between telomere length and telomerase in human leukocyte differentiation and aging. J Leukoc Biol 2001, 70:861-867.
64. Allsopp R.C., Vaziri H., Patterson C., Goldstein S., Younglai E.V., Futcher A.B., et al. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci 1992, 89:10114-10118.
65. Duncan E.L., Wadhwa R., Kaul S.C. Senescence and immortalization of human cells. Biogerontol 2000, 103-121.
66. Dhaene K., Van Marck E., Parwaresch R. Telomeres, telomerase and cancer: an update. Virchows Arch 2000, 437:1-16.
67. Helder M.N., Wisman G.B.A., van der Zee A.G.J. Telomerase and telomeres: from basic biology to cancer treatment. Cancer Invest 2002, 20(1):82-101.
68. Wright W.E., Shay J.W. Telomere positional effect and the regulation of cellular senescence. Trends Genet 1992, 8:193-197.
69. Greider C.W., Blackburn E.H. Identification of a specific telomere terminal transferase enzyme with two kinds of primer specificity. Cell 1985, 51:405-413.
70. Shippen-Lentz D., Blackburn E.H. Functional evidence for an RNA template in telomerase. Science 1990, 247:546-552.
71. Hastie N.D., Dempster M., Dunlop M.G., Thompson A.M., Green D.K., Allshire R.C. Telomere reduction in human colorectal carcinoma and with ageing. Nature 1990, 346:866-868.
72. de Lange T., Shiue L., Myers M.R., Cox D.R., Naylor S.L., Killery A.M., et al. Structure and variability of human chromosome ends. Mol Cell Biol 1990, 10:518-527.
73. Morin G.B. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell 1989, 59:521-529.
74. Counter C.M., Avilon A.A., LeFeuvre C.E., Stewert M., Greider C.W., Harley C.B., et al. Telomere shortening associated with chromosome instability is arrested in immortal cells, which express telomerase activity. EMBO J 1992, 11:1921-1929.
75. Chiu C., Harley C.B. Replicative senescence and cell immortality: the role of telomeres and telomerase. Proc Soc Exp Biol Med 1997, 214:99-106.
76. Feng J, Funk WD, Wang SS, Weinrich SL, Avilion AA, Chiu CP, et al. The RNA component of human telomerase. Science 1995;269:1236-41.
77. Nakamura T.M., Morin G.B., Chapman K.B., Weinrich S.L., Andrews W.H., Lingner J., et al. Telomerase catalytic subunit homologs from fission yeast and humans. Science 1997, 277:955-959.
78. Bodnar A.G., Ouellette M., Frolkis M., Holt S.E., Chiu C., Morin G.B., et al. Extension of life span by introduction of telomerase into normal human cells. Science 1998, 279:349-352.
79. Shay J.W., Wright W.E. Telomerase: a target for cancer therapeutics. Cancer Cell 2002, 2:257-265.
80. Rowley PR. Development of telomerase inhibitors. Expert Opin Ther Patents 2001;11(12):1815-23.
81. Perry P.J., Arnold J.R.P., Jenkins T.C. Telomerase inhibitors for the treatment of cancer: the current perspective. Expert Opin Investig Drugs 2001, 10(12):2141-2156.
82. Rudolph K.L., Chang S., Lee H.W., Blasco M., Gottleib G.J., Greider C. Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell 1999, 96:701-712.
83. Wilmut I., et al. Viable offspring derived from fetal and adult mammalian cells. Nature 1997, 385:810-813.
84. Lanza R.P., et al. Extension of cell life-span and telomere length in animals cloned from senescent somatic cells. Science 2000, 88:665-669.
85. Hayflick L. How and why we age 1996, Ballantine books, New York City, NY.
86. Hayflick L. Biological aging is no longer an unsolved problem. Ann N Y Acad Sci 2007, 1100:1-13.
87. and http://www.entropysimple.com/.
88. Hayflick L. How and why we age. Exp Gerontol 1998, 33:639-653.
89. Shay J.W., Wright W.E. Hayflick, his limit, and cellular ageing. Nat Rev 2000, 1:72-76.
90. Houck J.C., Sharma V.K., Hayflick L. Functional failures of cultured human diploid fibroblasts after continued population doublings. Proc Soc Exp Biol Med 1971, 137:331-333.
91. Hayflick L. Cell Aging. Annual review of gerontology and geriatrics 1980, I:26-67. Springer Publishing Co, NYC.